AVE9633
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVE9633, covering 2009-05-14 to 2009-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia [Phase 1]